- $10.91bn
- $15.22bn
- $5.38bn
- 35
- 50
- 75
- 53
Annual balance sheet for Albemarle, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 747 | 439 | 1,499 | 890 | 1,192 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 638 | 700 | 1,449 | 1,835 | 1,066 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,206 | 2,008 | 5,187 | 5,217 | 3,842 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,491 | 6,064 | 7,091 | 9,633 | 9,450 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 10,451 | 10,974 | 15,457 | 18,271 | 16,610 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,802 | 1,874 | 2,741 | 3,560 | 1,966 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,183 | 5,349 | 7,474 | 8,858 | 6,648 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 4,268 | 5,625 | 7,983 | 9,412 | 9,962 |
| Total Liabilities & Shareholders' Equity | 10,451 | 10,974 | 15,457 | 18,271 | 16,610 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |